首页>
外国专利>
MARKER GENES BASED ON THALIDOMIDE TREATMENT FOR SCREENING OF DRUG INDUCING TERATOGENICITY AND SCREENING METHOD USING THEREOF
MARKER GENES BASED ON THALIDOMIDE TREATMENT FOR SCREENING OF DRUG INDUCING TERATOGENICITY AND SCREENING METHOD USING THEREOF
展开▼
机译:基于三倍体处理的MARKER基因筛查药物致突变性的方法及其筛选方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A marker gene, a DNA microarray chip for screening the teratogenecity inducing drugs, and a method for screening the teratogenecity inducing drugs by using the chip are provided to the drugs inducing teratogenecity to be screened effectively. A marker gene is used to screen the teratogenecity inducing drugs and comprises the gene selected from Genebank NM_032199 [AT rich interactive domain 5B (MRF1-like)], Genebank BX647857 [Ankyrin repeat and SOCS box-containing 5], Genebank NM_013314 [B-cell linker], Genebank AB018258 [ATPase, Class V, type 10B], Genebank BX111592 [Transcribed locus], etc.
展开▼